These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33945371)

  • 1. Comparative safety review of current treatment options for chronic low back pain and unmet needs: a narrative review.
    Jovanovic F; Pirvulescu I; Knezevic E; Candido KD; Knezevic NN
    Expert Opin Drug Saf; 2021 Sep; 20(9):1005-1033. PubMed ID: 33945371
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic management of chronic low back pain: synthesis of the evidence.
    White AP; Arnold PM; Norvell DC; Ecker E; Fehlings MG
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S131-43. PubMed ID: 21952185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids compared to placebo or other treatments for chronic low-back pain.
    Chaparro LE; Furlan AD; Deshpande A; Mailis-Gagnon A; Atlas S; Turk DC
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004959. PubMed ID: 23983011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentinoids for chronic low back pain: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Shanthanna H; Gilron I; Thabane L; Devereaux PJ; Bhandari M; AlAmri R; Rajarathinam M; Kamath S
    BMJ Open; 2016 Nov; 6(11):e013200. PubMed ID: 28186946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for chronic non-specific low back pain: current and future options.
    Koes BW; Backes D; Bindels PJE
    Expert Opin Pharmacother; 2018 Apr; 19(6):537-545. PubMed ID: 29578822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.
    Shanthanna H; Gilron I; Rajarathinam M; AlAmri R; Kamath S; Thabane L; Devereaux PJ; Bhandari M
    PLoS Med; 2017 Aug; 14(8):e1002369. PubMed ID: 28809936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of chronic lower back pain.
    Migliorini F; Maffulli N; Eschweiler J; Betsch M; Catalano G; Driessen A; Tingart M; Baroncini A
    Expert Opin Pharmacother; 2021 Jan; 22(1):109-119. PubMed ID: 32885995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Opioid Analgesics for the Management of Chronic Low Back Pain: An Evidence from Bayesian Network Meta-Analysis.
    Boya C; Bansal D; Kanakagiri S; Ghai B
    Pain Physician; 2021 Jan; 24(1):73-82. PubMed ID: 33400430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.
    Davis MP
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):823-31. PubMed ID: 27253690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.
    Shmagel A; Ngo L; Ensrud K; Foley R
    J Pain; 2018 Oct; 19(10):1104-1112. PubMed ID: 29678564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline.
    Chou R; Huffman LH; ;
    Ann Intern Med; 2007 Oct; 147(7):505-14. PubMed ID: 17909211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis.
    Chung JW; Zeng Y; Wong TK
    Pain Physician; 2013; 16(6):E685-704. PubMed ID: 24284847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.
    Kivitz AJ; Gimbel JS; Bramson C; Nemeth MA; Keller DS; Brown MT; West CR; Verburg KM
    Pain; 2013 Jul; 154(7):1009-21. PubMed ID: 23628600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
    Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
    Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Analgesic and Other Pain-Relief Drugs to Manage Chronic Low Back Pain: Results from a National Survey.
    Gouveia N; Rodrigues A; Ramiro S; Eusébio M; Machado PM; Canhão H; Branco JC
    Pain Pract; 2017 Mar; 17(3):353-365. PubMed ID: 27206719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis.
    Weng C; Xu J; Wang Q; Lu W; Liu Z
    Osteoarthritis Cartilage; 2020 Jun; 28(6):721-734. PubMed ID: 32169731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy, Effectiveness and Safety of 5% Transdermal Lidocaine Patch for Chronic Low Back Pain: A Narrative Review.
    Santana JA; Klass S; Felix ER
    PM R; 2020 Dec; 12(12):1260-1267. PubMed ID: 32189475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Low Back Pain: Current Pharmacotherapeutic Therapies and a New Biological Approach.
    Pavelka K; Jarosova H; Sleglova O; Svobodova R; Votavova M; Milani L; Prochazka Z; Kotlarova L; Kostiuk P; Sliva J; Meroni AM
    Curr Med Chem; 2019; 26(6):1019-1026. PubMed ID: 29756567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back Pain.
    Zheng Y; Kostenbader K; Barrett T; Hisaw E; Giuliani MJ; Chen Y; Young JL
    Clin Ther; 2015 Jun; 37(6):1235-47. PubMed ID: 25913923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
    Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
    Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.